Surgery versus SABR for resectable non-small-cell lung cancer.
作者信息
Hamaji Masatsugu, Groth Shawn S, Sugarbaker David J, Burt Bryan M
机构信息
Department of Thoracic Surgery, Kyoto University Hospital, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
Division of Thoracic Surgery, Department of Surgery, Baylor College of Medicine, Houston, TX, 77030, USA.
出版信息
Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1.
Abstract
摘要
相似文献
1
Surgery versus SABR for resectable non-small-cell lung cancer.
Lancet Oncol. 2015 Aug;16(8):e372. doi: 10.1016/S1470-2045(15)00091-1.
2
Surgery versus SABR for resectable non-small-cell lung cancer.
Lancet Oncol. 2015 Aug;16(8):e370-1. doi: 10.1016/S1470-2045(15)00036-4.
3
Surgery versus SABR for resectable non-small-cell lung cancer.
Lancet Oncol. 2015 Aug;16(8):e371-2. doi: 10.1016/S1470-2045(15)00063-7.
4
Surgery versus SABR for resectable non-small-cell lung cancer.
Lancet Oncol. 2015 Aug;16(8):e372-3. doi: 10.1016/S1470-2045(15)00123-0.
5
Surgery versus SABR for resectable non-small-cell lung cancer - Authors' reply.
Lancet Oncol. 2015 Aug;16(8):e374-5. doi: 10.1016/S1470-2045(15)00154-0.
6
Surgery versus SABR for resectable non-small-cell lung cancer.
Lancet Oncol. 2015 Aug;16(8):e373-4. doi: 10.1016/S1470-2045(15)00145-X.
7
SABR vs surgery for NSCLC in the media.
Lancet Oncol. 2015 Sep;16(9):e422. doi: 10.1016/S1470-2045(15)00230-2.
8
SABR in early operable lung cancer: time for evidence.
Lancet Oncol. 2015 Jun;16(6):597-8. doi: 10.1016/S1470-2045(15)70225-1. Epub 2015 May 13.
9
Stereotactic radiotherapy or surgery for early-stage non-small-cell lung cancer.
Lancet Oncol. 2016 Feb;17(2):e41-e42. doi: 10.1016/S1470-2045(16)00026-7.
10
Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: Post hoc analysis dressed up as level-1 evidence?
J Thorac Cardiovasc Surg. 2015 Sep;150(3):468-71. doi: 10.1016/j.jtcvs.2015.06.086. Epub 2015 Jul 14.
引用本文的文献
1
Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.
J Thorac Dis. 2019 Nov;11(11):4404-4407. doi: 10.21037/jtd.2019.10.13.
2
Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.
Lung Cancer. 2017 Jan;103:6-10. doi: 10.1016/j.lungcan.2016.11.005. Epub 2016 Nov 9.
3
Stage I lung cancer-to operate or to radiate? that is the question.
J Thorac Dis. 2016 Sep;8(9):2324-2327. doi: 10.21037/jtd.2016.08.36.
4
Is surgery still the optimal treatment for stage I non-small cell lung cancer?
Transl Lung Cancer Res. 2016 Apr;5(2):183-9. doi: 10.21037/tlcr.2016.04.05.
Zotero 插件